Plurihormonal ACTH-GH Pituitary Adenoma: Case Report and Systematic Literature Review.

World Neurosurg

Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy. Electronic address:

Published: June 2018

AI Article Synopsis

  • Plurihormonal adenomas (PHAs) are a type of pituitary adenoma found in 10%-15% of cases, often producing prolactin and growth hormone, but this case highlights a rare instance of one producing both adrenocorticotropic hormone (ACTH) and growth hormone (GH).
  • A systematic review of literature revealed that only 20% of patients exhibited symptoms of both acromegaly and Cushing's disease, with most cases showing distinct cell types rather than a single cell producing both hormones.
  • The reported case involved a 60-year-old woman with incidental discovery of a microadenoma who underwent surgery and achieved clinical remission, emphasizing the importance of recognizing this rare condition and the ongoing debate regarding

Article Abstract

Background: Plurihormonal adenomas (PHAs) represent 10%-15% of all functioning pituitary adenomas. The most frequent hormonal associations are with prolactin and growth hormone (GH). Here we describe a rare case of functional adrenocorticotropic hormone (ACTH) and GH microadenoma and report our findings from a systematic literature review of PHA.

Methods: We searched PubMed using the terms "plurihormonal pituitary adenoma," "ACTH GH pituitary adenoma," and "acromegaly AND Cushing's disease". In the 17 articles that were selected for literature review, only 20% (4/20) of patients presented with clinical signs of both diseases. Histologically, 19 were pituitary adenomas composed of two distinct cell populations, while only in 1 case was there evidence of a single cell producing both ACTH and GH. In the case reported here, a 60-year-old woman was incidentally diagnosed with a pituitary microadenoma. Endocrine assessment documented increased levels of insulin-like growth factor 1 and GH; ACTH and cortisol values were within normal ranges. Echocardiography documented ventricular hypertrophy. Because of clinical and biochemical evidence of acromegaly, surgery was recommended. Postoperatively, hormonal replacement therapy was started because of adrenal insufficiency. Her antihypertensive therapy was discontinued due to evidence of normal blood pressure values. Histological examination revealed an ACTH-GH PHA with 2 distinct populations of secreting cells. At 3-year follow-up, the patient showed stable clinical remission and was no longer receiving hormonal replacement therapy.

Conclusions: This is an additional case to the 20 previously reported cases of ACTH-GH PHA. Awareness of this relatively rare entity is clinically relevant. The cytogenesis of ACTH-GH PHA remains a matter of debate, and several hypotheses have been postulated.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.wneu.2018.02.120DOI Listing

Publication Analysis

Top Keywords

literature review
12
acth-gh pha
12
systematic literature
8
pituitary adenomas
8
pituitary adenoma"
8
hormonal replacement
8
pituitary
6
case
5
plurihormonal acth-gh
4
acth-gh pituitary
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!